NSC 14613
CAS No. 91396-88-2
NSC 14613( NSC 14613; N’-phenyl-hydrazine-Isonicotinic acid )
Catalog No. M16567 CAS No. 91396-88-2
PluriSln 1(NSC 14613) is an inhibitor of stearoyl-coA desaturase (SCD1), the key enzyme in oleic acid biosynthesis, revealing a unique role for lipid metabolism in hPSCs.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 28 | In Stock |
|
10MG | 47 | In Stock |
|
25MG | 76 | In Stock |
|
50MG | 110 | In Stock |
|
100MG | 160 | In Stock |
|
200MG | 228 | In Stock |
|
500MG | 383 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNSC 14613
-
NoteResearch use only, not for human use.
-
Brief DescriptionPluriSln 1(NSC 14613) is an inhibitor of stearoyl-coA desaturase (SCD1), the key enzyme in oleic acid biosynthesis, revealing a unique role for lipid metabolism in hPSCs.
-
DescriptionPluriSln 1(NSC 14613) is an inhibitor of stearoyl-coA desaturase (SCD1), the key enzyme in oleic acid biosynthesis, revealing a unique role for lipid metabolism in hPSCs.
-
SynonymsNSC 14613; N’-phenyl-hydrazine-Isonicotinic acid
-
PathwayMetabolic Enzyme/Protease
-
TargetDehydrogenase
-
RecptorSCD
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number91396-88-2
-
Formula Weight213.24
-
Molecular FormulaC12H11N3O
-
Purity>98%(HPLC)
-
SolubilityDMSO: 43 mg/mL (201.65 mM)
-
SMILESO=C(NNC1=CC=CC=C1)C2=CC=NC=C2
-
Chemical NameN'-phenylisonicotinohydrazide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ben-David U, et al. Cell Stem Cell, 2013, 12(2), 167-179.
molnova catalog
related products
-
3-(IMIDAZOL-4-YL)PRO...
3-(IMIDAZOL-4-YL)PROPIONIC ACID is a product of histidine metabolism and may involve oxidation or transamination.
-
Teriflunomide
Teriflunomide is the active metabolite of leflunomide, and it acts as an immunomodulatory agent by inhibiting pyrimidine synthesis.
-
Mycophenolate mofeti...
Mycophenolate mofetil is the 2-morpholinoethyl ester of mycophenolic acid (MPA), an immunosuppressive agent, inosine monophosphate dehydrogenase (IMPDH) inhibitor.